Epigenetic Variability of Ribosomal Cistrons of Acrocentric Chromatids of Chromosomes 14 in Fetuses and Newborns with Down Syndrome

Following the completion of the Human Genome Project, the strategic focus of modern genetics shifted towards functional genomics, encompassing non-coding regions of DNA, including total non-coding DNA and satellite stalks with ribosomal cistrons. These consist of repetitive sequences of nucleotides localized in heterochromatin, the functions of which still require clarification. The present study investigates the activity of ribosomal cistrons within chromatid satellite stalks (NOR heterochromatin) of acrocentric chromosomes in patients with Down Syndrome +21 (DS). The study comprised: 29 healthy fetuses (441 metaphases from cultivated amniotic fluid); 8 fetuses with DS (190 metaphases from cultivated amniotic fluid); 10 healthy newborns (290 metaphases from cultivated lymphocytes); 10 newborn patients with DS (273 metaphases from cultivated lymphocytes) including: 5 newborn patients with trisomy DS (81 metaphases) and 5 mosaic form of newborns with DS (46, XX or 46, XY/47, XX, +21 or 47, XY, +21) (192 metaphases). The activity of ribosomal cistrons of chromatid on the 14 chromosomes included in associations in the control group (healthy fetuses and healthy newborns) corresponding to the order: 21 > 14 = 22 = 13 > 15 and 21 > 14 > 22 > 13 > 15, respectively. In fetuses with DS (21 > 22 > 15 > 13 > 14), in newborns with DS (21 > 13 > 15 = 22 > 14), and with mosaicism of cells of newborns with DS (21 > 13 > 15 > 22 > 14), a statistically significant decrease in the activity of entering associations of chromatids 14 chromosomes was noted. It is noteworthy that, in fetuses, in newborns, and with mosaicism of cells of newborns with DS activity of entering in associations of 14 chromatids with homologous 14 chromatids were not determined (21:21 > 13:13 > 15:15 > 22:22 > 14:14; 21:21 > 22:22 > 13:13 > 15: 15 > 14:14 and 21:21 > 13:13 > 22:22 > 15:15 > 14:14). In fetuses and newborns (control group), the order was: 21:21 > 22:22 > 14:14 > 13:13 = 15:15 and 14 : 14 = 22:22 > 21:21 > 13:13 > 15 : 15, respectively. These results indicate that in DS, the ribosomal cistrons of chromatids on chromosomes 14 undergo epigenetic changes, leading to a reduction in the activity of ribosomal cistrons on these chromatids. This provides a crucial foundation for the prevention, diagnosis, and treatment of DS. The study of ribosomal gene activity at the level of different acrocentric chromosomes in pathologies represents a new direction for medicine, offering insights into both disease diagnosis and the development of novel treatment strategies in the future.

Authors

Institutions

Publication Details

Journal
Cytology and Genetics
Published
2024-09-20
DOI
https://doi.org/10.3103/s0095452724050074
Citations
1
Primary Topic
RNA modifications and cancer
Type
article
Field-Weighted Citation Impact
0.23
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Epigenetic Variability of Ribosomal Cistrons of Acrocentric Chromatids of Chromosomes 14 in Fetuses and Newborns with Down Syndrome

T Lezhava, T Buadze, Nino Sigua, T Sigua et al.
1 citations
Cytology and Genetics
RNA modifications and cancer
0.23
article

Epigenetic Variability of Ribosomal Cistrons of Acrocentric Chromatids of Chromosomes 14 in Fetuses and Newborns with Down Syndrome

T Lezhava, T Buadze, Nino Sigua, T Sigua, M Gaiozishvili, Natia Kulijanashvili, Tinatin Jokhadze
article en
1 citations

Abstract

Following the completion of the Human Genome Project, the strategic focus of modern genetics shifted towards functional genomics, encompassing non-coding regions of DNA, including total non-coding DNA and satellite stalks with ribosomal cistrons. These consist of repetitive sequences of nucleotides localized in heterochromatin, the functions of which still require clarification. The present study investigates the activity of ribosomal cistrons within chromatid satellite stalks (NOR heterochromatin) of acrocentric chromosomes in patients with Down Syndrome +21 (DS). The study comprised: 29 healthy fetuses (441 metaphases from cultivated amniotic fluid); 8 fetuses with DS (190 metaphases from cultivated amniotic fluid); 10 healthy newborns (290 metaphases from cultivated lymphocytes); 10 newborn patients with DS (273 metaphases from cultivated lymphocytes) including: 5 newborn patients with trisomy DS (81 metaphases) and 5 mosaic form of newborns with DS (46, XX or 46, XY/47, XX, +21 or 47, XY, +21) (192 metaphases). The activity of ribosomal cistrons of chromatid on the 14 chromosomes included in associations in the control group (healthy fetuses and healthy newborns) corresponding to the order: 21 > 14 = 22 = 13 > 15 and 21 > 14 > 22 > 13 > 15, respectively. In fetuses with DS (21 > 22 > 15 > 13 > 14), in newborns with DS (21 > 13 > 15 = 22 > 14), and with mosaicism of cells of newborns with DS (21 > 13 > 15 > 22 > 14), a statistically significant decrease in the activity of entering associations of chromatids 14 chromosomes was noted. It is noteworthy that, in fetuses, in newborns, and with mosaicism of cells of newborns with DS activity of entering in associations of 14 chromatids with homologous 14 chromatids were not determined (21:21 > 13:13 > 15:15 > 22:22 > 14:14; 21:21 > 22:22 > 13:13 > 15: 15 > 14:14 and 21:21 > 13:13 > 22:22 > 15:15 > 14:14). In fetuses and newborns (control group), the order was: 21:21 > 22:22 > 14:14 > 13:13 = 15:15 and 14 : 14 = 22:22 > 21:21 > 13:13 > 15 : 15, respectively. These results indicate that in DS, the ribosomal cistrons of chromatids on chromosomes 14 undergo epigenetic changes, leading to a reduction in the activity of ribosomal cistrons on these chromatids. This provides a crucial foundation for the prevention, diagnosis, and treatment of DS. The study of ribosomal gene activity at the level of different acrocentric chromosomes in pathologies represents a new direction for medicine, offering insights into both disease diagnosis and the development of novel treatment strategies in the future.

Cytology and GeneticsVol. 58(5)
Tbilisi State University (GE), AIDS and Clinical Immunology Research Center (GE)
Zero hunger
Openalex Percentile: Top 42%
RNA modifications and cancer
0.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.